This announcement is a separate document:
中国国际金融股份有限公司关于上海交易所《关于上海微创心脉医疗科技（集团）股份有限公司2023年年度报告的信息披露监管问询函》有关事项之核查意见
Verification opinion on relevant matters regarding the information disclosure and regulatory inquiry letter on the 2023 annual report of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. by China International Finance Co., Ltd. to Shanghai Stock Exchange.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.